Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy

scientific article published in February 2005

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JACC.2004.10.057
P698PubMed publication ID15708700
P5875ResearchGate publication ID8023830

P50authorJohan LindbäckQ43299193
Lars WallentinQ6230815
Tomas JernbergQ61894825
Bertil LindahlQ89147388
Nina JohnstonQ96065252
Per VengeQ96157062
Mats StridsbergQ98215861
P2860cites workEssential biochemistry and physiology of (NT-pro)BNP.Q35677297
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectacute coronary syndromeQ266018
artery diseaseQ18965518
coronary artery diseaseQ844935
revascularizationQ7317735
P304page(s)533-541
P577publication date2005-02-01
P1433published inJournal of the American College of CardiologyQ2984355
P1476titleSerial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy
P478volume45

Reverse relations

cites work (P2860)
Q48409814Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure
Q36814482Analyzing Dynamic Changes of Laboratory Indexes in Patients with Acute Heart Failure Based on Retrospective Study
Q30238936B-type natriuretic peptide-guided treatment for heart failure.
Q36724549B-type natriuretic peptide: a critical review
Q36245755B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review
Q37755062B-type natriuretic peptides in heart failure: update on clinical applications and limitations
Q37207294Biomarkers in Acute Coronary Syndrome
Q36359877Cardiac biomarkers: a contemporary status report
Q92661558Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
Q33691730Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
Q37449563Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.
Q38041973Growth differentiation factor 15 in heart failure: an update
Q48795541Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy
Q48125660Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).
Q48793828N-terminal pro-B-type natriuretic peptide is associated with severity of the coronary lesions in unstable angina patients with preserved left ventricular function
Q48332374N-terminal pro-brain natriuretic peptide and coronary artery disease
Q48718403N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes.
Q37020155National Academy of Clinical Biochemistry (NACB) laboratory medicine guidelines on the clinical utilization and analytical issues for cardiac biomarker testing in heart failure
Q39185614Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
Q40165610Prognostic Value of Serial N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients With Acute Myocardial Infarction
Q49287518RETRACTED: Brain Natriuretic Peptide Levels in Acute Inferior Myocardial Infarction
Q48591877Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes.
Q38089931Review on natriuretic peptides: where we are, where we are going
Q49111539Risk prediction in acute coronary syndrome from serial in-hospital measurements of N-terminal pro-B-type natriuretic peptide.
Q38376243Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
Q52628737Sleep Study-Guided Multidisciplinary Therapy (SGMT) for Patients with Acute Coronary Syndrome: Trial Rationale and Design
Q37277937The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.
Q37694917Usefulness of NT-proBNP in the Follow-Up of Patients after Myocardial Infarction.
Q80843600[Risk stratification of acute coronary syndromes]

Search more.